18+ years old Type 1 diabetes and used insulin for at least one year A1c of 7.5% to 10% Administering insulin via multiple daily injections (MDI) or insulin pump user with total daily insulin between 0.3 and 1.5 units per kilogram Body Mass Index (BMI) greater than 18.5 (Calculate your BMI here) Exclusion criteria include: A history of type 2 diabetes Past treatment for type 1 diabetes with any other glucose-lowering drug except basal and bolus insulin during the last three months Severe hypoglycemia or diabetic ketoacidosis in the past three months For a full list of inclusion and exclusion criteria see here
Once you reach your goal weight, your doctor may recommend continuing at a maintenance dose rather than stopping completely
Despite its advantages, its important to acknowledge GHK-Cus limitations when compared to traditional acne treatments in a research context: Limited Direct Evidence for Active Acne Vulgaris: While it has anti-inflammatory properties, there is currently limited direct clinical evidence specifically demonstrating GHK-Cu as a primary treatment for active acne breakouts (e.g., reducing papules, pustules, or cysts)
Real-time PCR Total RNA, from either frozen liver tissues or cultured cells, was isolated by phenol-chloroform extraction
Mol Metabolism
Another interesting aspect of this study is that it demonstrated that bacteria in the gut, the so-called microbiome, can be responsible for affecting levels of chemicals in the blood
